Key statistics
As of last trade, Exagen Inc (XGN:NMQ) traded at 3.35, 25.46% above the 52 week low of 2.67 set on Mar 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.62 |
|---|---|
| High | 3.65 |
| Low | 3.33 |
| Bid | 3.35 |
| Offer | 3.38 |
| Previous close | 3.55 |
| Average volume | 302.66k |
|---|---|
| Shares outstanding | 22.66m |
| Free float | 15.01m |
| P/E (TTM) | -- |
| Market cap | 80.45m USD |
| EPS (TTM) | -0.9257 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 16:37 GMT.
More ▼
- Exagen Inc. to Participate in Upcoming Investor Conferences
- Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
- Exagen Inc. Announces Select Preliminary 2025 Financial Results
- Exagen Inc. to Participate in Fourth Quarter Investor Conferences
- Exagen Inc. Reports Strong Q3 2025 Results
- Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
- Exagen Inc. to Participate in Third Quarter Investor Conferences
- Exagen Inc. Reports Strong Q2 2025 Results
- Exagen Inc. Appoints Chas McKhann to Board of Directors
- Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
More ▼
